131 results on '"Hegarty, S."'
Search Results
2. Sports stars: analyzing the performance of astronomers at visualization-based discovery
- Author
-
Fluke, C. J., Parrington, L., Hegarty, S., MacMahon, C., Morgan, S., Hassan, A. H., and Kilborn, V. A.
- Subjects
Astrophysics - Instrumentation and Methods for Astrophysics - Abstract
In this data-rich era of astronomy, there is a growing reliance on automated techniques to discover new knowledge. The role of the astronomer may change from being a discoverer to being a confirmer. But what do astronomers actually look at when they distinguish between "sources" and "noise?" What are the differences between novice and expert astronomers when it comes to visual-based discovery? Can we identify elite talent or coach astronomers to maximize their potential for discovery? By looking to the field of sports performance analysis, we consider an established, domain-wide approach, where the expertise of the viewer (i.e. a member of the coaching team) plays a crucial role in identifying and determining the subtle features of gameplay that provide a winning advantage. As an initial case study, we investigate whether the SportsCode performance analysis software can be used to understand and document how an experienced HI astronomer makes discoveries in spectral data cubes. We find that the process of timeline-based coding can be applied to spectral cube data by mapping spectral channels to frames within a movie. SportsCode provides a range of easy to use methods for annotation, including feature-based codes and labels, text annotations associated with codes, and image-based drawing. The outputs, including instance movies that are uniquely associated with coded events, provide the basis for a training program or team-based analysis that could be used in unison with discipline specific analysis software. In this coordinated approach to visualization and analysis, SportsCode can act as a visual notebook, recording the insight and decisions in partnership with established analysis methods. Alternatively, in situ annotation and coding of features would be a valuable addition to existing and future visualisation and analysis packages., Comment: 16 pages, 7 figures; accepted for publication in PASP Special Issue: Techniques and Methods for Astrophysical Data Visualization
- Published
- 2017
- Full Text
- View/download PDF
3. The Australian Square Kilometre Array Pathfinder: Performance of the Boolardy Engineering Test Array
- Author
-
McConnell, D., Allison, J. R., Bannister, K., Bell, M. E., Bignall, H. E., Chippendale, A. P., Edwards, P. G., Harvey-Smith, L., Hegarty, S., Heywood, I., Hotan, A. W., Indermuehle, B. T., Lenc, E., Marvil, J., Popping, A., Raja, W., Reynolds, J. E., Sault, R. J., Serra, P., Voronkov, M. A., Whiting, M., Amy, S. W., Axtens, P., Ball, L., Bateman, T. J., Bock, D. C. -J., Bolton, R., Brodrick, D., Brothers, M., Brown, A. J., Bunton, J. D., Cheng, W., Cornwell, T., DeBoer, D., Feain, I., Gough, R., Gupta, N., Guzman, J. C., Hampson, G. A., Hay, S., Hayman, D. B., Hoyle, S., Humphreys, B., Jacka, C., Jackson, C. A., Jackson, S., Jeganathan, K., Joseph, J., Koribalski, B. S., Leach, M., Lensson, E. S., MacLeod, A., Mackay, S., Marquarding, M., McClure-Griffiths, N. M., Mirtschin, P., Mitchell, D., Neuhold, S., Ng, A., Norris, R., Pearce, S., Qiao, R. Y., Schinckel, A. E. T., Shields, M., Shimwell, T. W., Storey, M., Troup, E., Turner, B., Tuthill, J., Tzioumis, A., Wark, R. M., Westmeier, T., Wilson, C., and Wilson, T.
- Subjects
Astrophysics - Instrumentation and Methods for Astrophysics - Abstract
We describe the performance of the Boolardy Engineering Test Array (BETA), the prototype for the Australian Square Kilometre Array Pathfinder telescope ASKAP. BETA is the first aperture synthesis radio telescope to use phased array feed technology, giving it the ability to electronically form up to nine dual-polarization beams. We report the methods developed for forming and measuring the beams, and the adaptations that have been made to the traditional calibration and imaging procedures in order to allow BETA to function as a multi-beam aperture synthesis telescope. We describe the commissioning of the instrument and present details of BETA's performance: sensitivity, beam characteristics, polarimetric properties and image quality. We summarise the astronomical science that it has produced and draw lessons from operating BETA that will be relevant to the commissioning and operation of the final ASKAP telescope., Comment: Accepted for publication in PASA
- Published
- 2016
- Full Text
- View/download PDF
4. Self-reported awareness of genetic testing, the impact of family history, and access to clinical trials for people diagnosed with ovarian cancer in Australia.
- Author
-
Roczo, D, Alford, V, Trainer, A, DeFazio, A, Pearn, A, Delaney, C, Cotter, M, Hegarty, S, Roczo, D, Alford, V, Trainer, A, DeFazio, A, Pearn, A, Delaney, C, Cotter, M, and Hegarty, S
- Abstract
OBJECTIVES: To assess the understanding of people diagnosed with ovarian cancer regarding genetic testing; to understand knowledge gaps among people diagnosed with ovarian cancer that may impact best practice care; and to monitor overall changes in understanding from 2015 to 2022. DESIGN: Longitudinal 'opt-in' study using an online survey tool at three timepoints: 2015, 2018 and 2022. PARTICIPANTS: People in Australia (or their families / caregivers) diagnosed with ovarian cancer between 2010 and 2022). MAIN OUTCOME MEASURES: Self-reported awareness of heritable risk factors for ovarian cancer, genetic testing approaches and participation in clinical trials. RESULTS: The study indicated that there have been improvements in the understanding and awareness of people diagnosed with ovarian cancer regarding familial risk (an increase from 43.6% (45 of 149) in 2015 to 62.9% (166 of 264) in 2022); but people were less likely to be aware of the difference between somatic (tumour) and germline testing (120 of 266, 45.1%). However, there were self-reported improvements to clinical trial access in non-metropolitan areas (12 of 64, 18.8% in 2022 compared to 22 of 145, 15.2% in 2018), bringing it on par with metropolitan areas (32 of 169, 18.9% in 2022). CONCLUSIONS: Despite improved awareness about genetic testing among people diagnosed with ovarian cancer, there remain knowledge gaps in understanding of genetic testing types (germline and somatic) and gene variant targeted therapies; and further work to improve clinical trial awareness and access is required.
- Published
- 2024
5. Network patterns of university-industry collaboration: A case study of the chemical sciences in Australia
- Author
-
Gallagher, C, Lusher, D, Koskinen, J, Roden, B, Wang, P, Gosling, A, Polyzos, A, Stenzel, M, Hegarty, S, Spurling, T, Simpson, G, Gallagher, C, Lusher, D, Koskinen, J, Roden, B, Wang, P, Gosling, A, Polyzos, A, Stenzel, M, Hegarty, S, Spurling, T, and Simpson, G
- Abstract
University–industry (U–I) collaboration takes on many forms, from research services, teaching and training, to curiosity-led research. In the chemical industries, academic chemists generate new knowledge, address novel problems faced by industry, and train the future workforce in cutting-edge methods. In this study, we examine the dynamic structures of collaborative research contracts and grants between academic and industry partners over a 5-year period within a research-intensive Australian university. We reconstruct internal contract data provided by a university research office as records of its collaborations into a complex relational database that links researchers to research projects. We then structure this complex relational data as a two-mode network of researcher-project collaborations for utilisation with Social Network Analysis (SNA)—a relational methodology ideally suited to relational data. Specifically, we use a stochastic actor-oriented model (SAOM), a statistical network model for longitudinal two-mode network data. Although the dataset is complicated, we manage to replicate it exactly using a very parsimonious and relatable network model. Results indicate that as academics gain experience, they become more involved in direct research contracts with industry, and in research projects more generally. Further, more senior academics are involved in projects involving both industry partners and other academic partners of any level. While more experienced academics are also less likely to repeat collaborations with the same colleagues, there is a more general tendency in these collaborations, regardless of academic seniority or industry engagement, for prior collaborations to predict future collaborations. We discuss implications for industry and academics.
- Published
- 2023
6. Exploring the experiences and priorities of women with a diagnosis of ovarian cancer
- Author
-
Pasvanis, M, Hegarty, S, Russell, H, Peate, M, Marino, JLL, Pasvanis, M, Hegarty, S, Russell, H, Peate, M, and Marino, JLL
- Abstract
PURPOSE: Ovarian cancer is the third most common gynaecological cancer among women, yet remains under-researched. Past studies suggest that women who present with ovarian cancer have more supportive care needs compared to women experiencing other gynaecological cancers. This study explores the experiences and priorities of women with a diagnosis of ovarian cancer and whether age may influence these needs and experiences. METHODS: Participants were recruited by a community organization, Ovarian Cancer Australia (OCA), via a social media campaign promoted on Facebook. Participants were asked to rank priorities around living with ovarian cancer, and to endorse which supports and resources they had used to address those priorities. Distributions of priority rankings and resource use were compared by age (19-49 vs. 50+ years). RESULTS: Two hundred and eighty-eight people completed the consumer survey and most respondents were 60-69 years (33.7%). Priorities did not vary by age. Fear of cancer recurrence was identified by 51% respondents as the most challenging aspect of having ovarian cancer. Compared with older respondents, a higher proportion of young participants were more inclined to use a mobile app version of the OCA resilience kit (25.8% vs 45.1%, p=0.002) and expressed interest in using a fertility preservation decision aid (2.4% vs 25%, p<0.001). CONCLUSION: Fear of recurrence was participants' primary concern, presenting an opportunity to develop interventions. Information delivery needs to consider age-specific preferences to better reach the target audience. Fertility is more important to younger women and a fertility preservation decision aid may address this need.
- Published
- 2023
7. Opportunities, approaches and challenges to the engagement of citizens in filling small water body data gaps
- Author
-
Kelly-Quinn, M., primary, Biggs, J. N., additional, Brooks, S., additional, Fortuño, P., additional, Hegarty, S., additional, Jones, J. I., additional, and Regan, F., additional
- Published
- 2022
- Full Text
- View/download PDF
8. P1722: CHANGES IN ACUTE HEPATIC PORPHYRIA HEALTH IMPACTS SINCE INITIAL DIAGNOSIS: RESULTS FROM THE PORPHYRIA WORLDWIDE PATIENT EXPERIENCE RESEARCH (POWER) STUDY
- Author
-
Nance, D., primary, Lyon, D., additional, Hegarty, S., additional, Falchetto, R., additional, Barman-Aksözen, J., additional, Mnif, T., additional, Meninger, S., additional, Lombardelli, S., additional, and Dickey, A., additional
- Published
- 2022
- Full Text
- View/download PDF
9. PB2354: THE IMPACT OF ACUTE HEPATIC PORPHYRIA ON MENTAL HEALTH: RESULTS FROM THE PORPHYRIA WORLDWIDE PATIENT EXPERIENCE RESEARCH (POWER) STUDY
- Author
-
Nance, D., primary, Lyon, D., additional, Hegarty, S., additional, Falchetto, R., additional, Barman-Aksözen, J., additional, Matos, J. E., additional, Meninger, S., additional, Lombardelli, S., additional, and Dickey, A., additional
- Published
- 2022
- Full Text
- View/download PDF
10. Please Place Your Seat in the Full Upright Position: A Technical Framework for Landing Upright Radiation Therapy in the 21st Century
- Author
-
Hegarty, S, Hardcastle, N, Korte, J, Kron, T, Everitt, S, Rahim, S, Hegi-Johnson, F, Franich, R, Hegarty, S, Hardcastle, N, Korte, J, Kron, T, Everitt, S, Rahim, S, Hegi-Johnson, F, and Franich, R
- Abstract
Delivering radiotherapy to patients in an upright position can allow for increased patient comfort, reduction in normal tissue irradiation, or reduction of machine size and complexity. This paper gives an overview of the requirements for the delivery of contemporary arc and modulated radiation therapy to upright patients. We explore i) patient positioning and immobilization, ii) simulation imaging, iii) treatment planning and iv) online setup and image guidance. Treatment chairs have been designed to reproducibly position seated patients for treatment and can be augmented by several existing immobilisation systems or promising emerging technologies such as soft robotics. There are few solutions for acquiring CT images for upright patients, however, cone beam computed tomography (CBCT) scans of upright patients can be produced using the imaging capabilities of standard Linacs combined with an additional patient rotation device. While these images will require corrections to make them appropriate for treatment planning, several methods indicate the viability of this approach. Treatment planning is largely unchanged apart from translating gantry rotation to patient rotation, allowing for a fixed beam with a patient rotating relative to it. Rotation can be provided by a turntable during treatment delivery. Imaging the patient with the same machinery as used in treatment could be advantageous for online plan adaption. While the current focus is using clinical linacs in existing facilities, developments in this area could also extend to lower-cost and mobile linacs and heavy ion therapy.
- Published
- 2022
11. Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variants
- Author
-
Loong, Lucy, primary, Cubuk, Cankut, additional, Choi, Subin, additional, Allen, Sophie, additional, Torr, Beth, additional, Garrett, Alice, additional, Loveday, Chey, additional, Durkie, Miranda, additional, Callaway, Alison, additional, Burghel, George J., additional, Drummond, James, additional, Robinson, Rachel, additional, Berry, Ian R., additional, Wallace, Andrew, additional, Eccles, Diana M., additional, Tischkowitz, Marc, additional, Ellard, Sian, additional, Ware, James S., additional, Hanson, Helen, additional, Turnbull, Clare, additional, Samant, S., additional, Lucassen, A., additional, Znaczko, A., additional, Shaw, A., additional, Ansari, A., additional, Kumar, A., additional, Donaldson, A., additional, Murray, A., additional, Ross, A., additional, Taylor-Beadling, A., additional, Taylor, A., additional, Innes, A., additional, Brady, A., additional, Kulkarni, A., additional, Hogg, A.-C., additional, Bowden, A. Ramsay, additional, Hadonou, A., additional, Coad, B., additional, McIldowie, B., additional, Speight, B., additional, DeSouza, B., additional, Mullaney, B., additional, McKenna, C., additional, Brewer, C., additional, Olimpio, C., additional, Clabby, C., additional, Crosby, C., additional, Jenkins, C., additional, Armstrong, C., additional, Bowles, C., additional, Brooks, C., additional, Byrne, C., additional, Maurer, C., additional, Baralle, D., additional, Chubb, D., additional, Stobo, D., additional, Moore, D., additional, O'Sullivan, D., additional, Donnelly, D., additional, Randhawa, D., additional, Halliday, D., additional, Atkinson, E., additional, Baple, E., additional, Rauter, E., additional, Johnston, E., additional, Woodward, E., additional, Maher, E., additional, Sofianopoulou, E., additional, Petrides, E., additional, Lalloo, F., additional, McRonald, F., additional, Pelz, F., additional, Frayling, I., additional, Evans, G., additional, Corbett, G., additional, Rea, G., additional, Clouston, H., additional, Powell, H., additional, Williamson, H., additional, Carley, H., additional, Thomas, H.J.W., additional, Tomlinson, I., additional, Cook, J., additional, Hoyle, J., additional, Tellez, J., additional, Whitworth, J., additional, Williams, J., additional, Murray, J., additional, Campbell, J., additional, Tolmie, J., additional, Field, J., additional, Mason, J., additional, Burn, J., additional, Bruty, J., additional, Callaway, J., additional, Grant, J., additional, Del Rey Jimenez, J., additional, Pagan, J., additional, VanCampen, J., additional, Barwell, J., additional, Monahan, K., additional, Tatton-Brown, K., additional, Ong, K.-R., additional, Murphy, K., additional, Andrews, K., additional, Mokretar, K., additional, Cadoo, K., additional, Smith, K., additional, Baker, K., additional, Brown, K., additional, Reay, K., additional, McKay Bounford, K., additional, Bradshaw, K., additional, Russell, K., additional, Stone, K., additional, Snape, K., additional, Crookes, L., additional, Reed, L., additional, Taggart, L., additional, Yarram, L., additional, Cobbold, L., additional, Walker, L., additional, Hawkes, L., additional, Busby, L., additional, Izatt, L., additional, Kiely, L., additional, Hughes, L., additional, Side, L., additional, Sarkies, L., additional, Greenhalgh, K.-L., additional, Shanmugasundaram, M., additional, Duff, M., additional, Bartlett, M., additional, Watson, M., additional, Owens, M., additional, Bradford, M., additional, Huxley, M., additional, Slean, M., additional, Ryten, M., additional, Smith, M., additional, Ahmed, M., additional, Roberts, N., additional, O'Brien, C., additional, Middleton, O., additional, Tarpey, P., additional, Logan, P., additional, Dean, P., additional, May, P., additional, Brace, P., additional, Tredwell, R., additional, Harrison, R., additional, Hart, R., additional, Kirk, R., additional, Martin, R., additional, Nyanhete, R., additional, Wright, R., additional, Davidson, R., additional, Cleaver, R., additional, Talukdar, S., additional, Butler, S., additional, Sampson, J., additional, Ribeiro, S., additional, Dell, S., additional, Mackenzie, S., additional, Hegarty, S., additional, Albaba, S., additional, McKee, S., additional, Palmer-Smith, S., additional, Heggarty, S., additional, MacParland, S., additional, Greville-Heygate, S., additional, Daniels, S., additional, Prapa, S., additional, Abbs, S., additional, Tennant, S., additional, Hardy, S., additional, MacMahon, S., additional, McVeigh, T., additional, Foo, T., additional, Bedenham, T., additional, Cranston, T., additional, McDevitt, T., additional, Clowes, V., additional, Tripathi, V., additional, McConnell, V., additional, Woodwaer, N., additional, Wallis, Y., additional, Kemp, Z., additional, Mullan, G., additional, Pierson, L., additional, Rainey, L., additional, Joyce, C., additional, Timbs, A., additional, Reuther, A.-M., additional, Frugtniet, B., additional, Husher, C., additional, Lawn, C., additional, Corbett, C., additional, Nocera-Jijon, D., additional, Reay, D., additional, Cross, E., additional, Ryan, F., additional, Lindsay, H., additional, Oliver, J., additional, Dring, J., additional, Spiers, J., additional, Harper, J., additional, Ciucias, K., additional, Connolly, L., additional, Tsang, M., additional, Brown, R., additional, Shepherd, S., additional, Begum, S., additional, Tadiso, T., additional, Linton-Willoughby, T., additional, Heppell, H., additional, Sahan, K., additional, Worrillow, L., additional, Allen, Z., additional, Barlett, M., additional, Watt, C., additional, and Hegarty, M., additional
- Published
- 2022
- Full Text
- View/download PDF
12. Photonic crystal lasers: from photonic crystal surface emitting lasers (PCSELs) to hybrid external cavity lasers (HECLs) and topological PhC lasers [Invited]
- Author
-
Iadanza, S., primary, Liles, A. A., additional, Butler, S. M., additional, Hegarty, S. P., additional, and O’Faolain, L., additional
- Published
- 2021
- Full Text
- View/download PDF
13. Developing an Australian multi-module clinical quality registry for gynaecological cancers: a protocol paper.
- Author
-
Heriot, N, Brand, A, Cohen, P, Hegarty, S, Hyde, S, Leung, Y, Zalcberg, JR, Rome, R, Heriot, N, Brand, A, Cohen, P, Hegarty, S, Hyde, S, Leung, Y, Zalcberg, JR, and Rome, R
- Abstract
INTRODUCTION: Gynaecological cancers collectively account for almost 10% of cancer diagnoses made in Australian women. The extent of variation in gynaecological cancer survival rates and treatment outcomes across Australia is not well documented. The purpose of the clinical quality registry described in this paper is to systematically monitor and improve quality of care provided to these women, and facilitate clinical process improvements to ensure better patient outcomes and greater adherence to best practice care. The registry infrastructure has been developed in conjunction alongside the inaugural ovarian, tubal and peritoneal (OTP) module, allowing for concurrent piloting of the methodology and one module. Additional tumour modules will be developed in time to cover the other gynaecological tumour types. METHOD AND ANALYSIS: The National Gynae-Oncology Registry (NGOR) aims to capture clinical data on all newly diagnosed cancers of the uterus, ovary, fallopian tubes, peritoneum, cervix, vulva and vagina in Australia with a view to using these data to support improved clinical care and increased adherence to 'best practice'. Data are sourced from existing clinical databases maintained by clinicians and/or hospital gynaecological cancer units. A pilot phase incorporating only OTP cancers has recently been conducted to assess the feasibility of the registry methodology and assess the support of a quality initiative of this nature among clinicians and other key stakeholders. ETHICS AND DISSEMINATION: The NGOR has received National Mutual Acceptance (NMA) ethics approval from Monash Health Human Research Ethics Committee (HREC), NMA HREC Reference Number: HREC/17/MonH/198. We also have approval from Mercy Health HREC and University of Tasmania HREC. Data will be routinely reported back to participating sites illustrating their performance against measures of agreed best practice. It is through this feedback system that the registry will support changes to quality of c
- Published
- 2020
14. Upright Radiation Therapy-A Historical Reflection and Opportunities for Future Applications
- Author
-
Rahim, S, Korte, J, Hardcastle, N, Hegarty, S, Kron, T, Everitt, S, Rahim, S, Korte, J, Hardcastle, N, Hegarty, S, Kron, T, and Everitt, S
- Abstract
Since the early days of megavoltage Radiation Therapy (RT), the potential of delivering treatment to a sub group of patients in an upright position has been recognized. Compared to lying horizontally, treating patients in an upright position offers potential benefits in terms of patient comfort especially for patients experiencing dyspnoea and saliva accumulation when lying down. Dosimetric benefits can also be gained from changes in the volume and location of lungs and heart in an upright position, which are potentially advantageous for clinical situations including Hodgkin's disease, lung and breast malignancies. Since the 1950's, upright stabilization mechanisms have ranged from standalone chair based apparatus to couch-top attachments with increasingly customizable solutions. The introduction of Computed-Tomography (CT) based three-dimensional (3D) dosimetry in the 1980's−90's necessitated image acquisition in a horizontal position (supine or prone), significantly reducing options for alternative patient positioning and upright techniques. Despite this, upright techniques have still been utilized where clinically indicated for palliative and novel approaches often involving non-standard treatment scenarios. More recently, a small number of centers have reported on specialized equipment capable of acquiring planning data with the patient in a vertical position. The possibility of acquiring planning quality Cone Beam CT (CBCT) on linear accelerators has recently reinvigorated the potential to deliver highly accurate and targeted treatments to patients in an upright position. This paper reflects on the historical applications of upright RT and explores new possibilities for this technology in modern RT departments.
- Published
- 2020
15. Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1and MSH2missense variants
- Author
-
Loong, Lucy, Cubuk, Cankut, Choi, Subin, Allen, Sophie, Torr, Beth, Garrett, Alice, Loveday, Chey, Durkie, Miranda, Callaway, Alison, Burghel, George J., Drummond, James, Robinson, Rachel, Berry, Ian R., Wallace, Andrew, Eccles, Diana M., Tischkowitz, Marc, Ellard, Sian, Ware, James S., Hanson, Helen, Turnbull, Clare, Samant, S., Lucassen, A., Znaczko, A., Shaw, A., Ansari, A., Kumar, A., Donaldson, A., Murray, A., Ross, A., Taylor-Beadling, A., Taylor, A., Innes, A., Brady, A., Kulkarni, A., Hogg, A.-C., Bowden, A. Ramsay, Hadonou, A., Coad, B., McIldowie, B., Speight, B., DeSouza, B., Mullaney, B., McKenna, C., Brewer, C., Olimpio, C., Clabby, C., Crosby, C., Jenkins, C., Armstrong, C., Bowles, C., Brooks, C., Byrne, C., Maurer, C., Baralle, D., Chubb, D., Stobo, D., Moore, D., O'Sullivan, D., Donnelly, D., Randhawa, D., Halliday, D., Atkinson, E., Baple, E., Rauter, E., Johnston, E., Woodward, E., Maher, E., Sofianopoulou, E., Petrides, E., Lalloo, F., McRonald, F., Pelz, F., Frayling, I., Evans, G., Corbett, G., Rea, G., Clouston, H., Powell, H., Williamson, H., Carley, H., Thomas, H.J.W., Tomlinson, I., Cook, J., Hoyle, J., Tellez, J., Whitworth, J., Williams, J., Murray, J., Campbell, J., Tolmie, J., Field, J., Mason, J., Burn, J., Bruty, J., Callaway, J., Grant, J., Del Rey Jimenez, J., Pagan, J., VanCampen, J., Barwell, J., Monahan, K., Tatton-Brown, K., Ong, K.-R., Murphy, K., Andrews, K., Mokretar, K., Cadoo, K., Smith, K., Baker, K., Brown, K., Reay, K., McKay Bounford, K., Bradshaw, K., Russell, K., Stone, K., Snape, K., Crookes, L., Reed, L., Taggart, L., Yarram, L., Cobbold, L., Walker, L., Walker, L., Hawkes, L., Busby, L., Izatt, L., Kiely, L., Hughes, L., Side, L., Sarkies, L., Greenhalgh, K.-L., Shanmugasundaram, M., Duff, M., Bartlett, M., Watson, M., Owens, M., Bradford, M., Huxley, M., Slean, M., Ryten, M., Smith, M., Ahmed, M., Roberts, N., O'Brien, C., Middleton, O., Tarpey, P., Logan, P., Dean, P., May, P., Brace, P., Tredwell, R., Harrison, R., Hart, R., Kirk, R., Martin, R., Nyanhete, R., Wright, R., Martin, R., Davidson, R., Cleaver, R., Talukdar, S., Butler, S., Sampson, J., Ribeiro, S., Dell, S., Mackenzie, S., Hegarty, S., Albaba, S., McKee, S., Palmer-Smith, S., Heggarty, S., MacParland, S., Greville-Heygate, S., Daniels, S., Prapa, S., Abbs, S., Tennant, S., Hardy, S., MacMahon, S., McVeigh, T., Foo, T., Bedenham, T., Cranston, T., McDevitt, T., Clowes, V., Tripathi, V., McConnell, V., Woodwaer, N., Wallis, Y., Kemp, Z., Mullan, G., Pierson, L., Rainey, L., Joyce, C., Timbs, A., Reuther, A.-M., Frugtniet, B., DeSouza, B., Husher, C., Lawn, C., Corbett, C., Nocera-Jijon, D., Reay, D., Cross, E., Ryan, F., Lindsay, H., Oliver, J., Dring, J., Spiers, J., Harper, J., Ciucias, K., Connolly, L., Tsang, M., Brown, R., Shepherd, S., Begum, S., Daniels, S., Tadiso, T., Linton-Willoughby, T., Heppell, H., Sahan, K., Worrillow, L., Allen, Z., Barlett, M., Watt, C., and Hegarty, M.
- Abstract
Conditions and thresholds applied for evidence weighting of within-codon concordance (PM5) for pathogenicity vary widely between laboratories and expert groups. Because of the sparseness of available clinical classifications, there is little evidence for variation in practice.
- Published
- 2022
- Full Text
- View/download PDF
16. MALFORMATION RISKS OF ANTIEPILEPTIC DRUG MONOTHERAPIES IN PREGNANCY: AN UPDATE FROM THE UK AND IRELAND EPILEPSY AND PREGNANCY REGISTERS
- Author
-
Boyle, AJ, Digangi, A, Mottram, LJ, Hamid, U, McNamee, L, White, G, Cross, LJM, McNamee, J, O'Kane, C, McAuley, DM, Campbell, E, Kennedy, F, Russell, A, Smithson, WH, Parsons, L, Robertson, I, Irwin, B, Liggan, B, Delanty, N, Morrison, PJ, Hunt, SJ, Craig, J, Morrow, J, Major, EH, O'Connor, P, Mullan, B, Savage, EM, McCormick, D, McDonald, S, Moore, O, Stevenson, M, Cairns, AP, McKavanagh, P, Lusk, L, Ball, PA, Trinick, TR, Duly, E, Verghis, RM, Agus, AM, Walls, GW, McCusker, S, James, B, Orr, C, Hamilton, A, Smyth, A, Harbinson, MT, Donnelly, PM, Ling, P, MacPherson, J, McCrossan, L, Wethers, G, O'Neill, FA, Forty, L, Di Florio, A, Gordon-Smith, K, Fraser, C, Jones, L, Jones, I, Craddock, N, Smith, DJ, Murphy, L, McKenna, S, Shirley, D, Hodgins, N, Damkat-Thomas, L, Shamsian, N, Yew, P, Lewis, H, Khan, K, Cooke, I, Hunt, S, McCauley, M, Mark, D, Leonard, C, Breen, H, Graydon, R, O'Gorman, C, Kirk, S, Blayney, GV, Hardy, CL, Stratton, S, Bhat, S, Cash, J, Cadden, I, Kennedy, P, Ellis, P, Collins, A, Dargin, A, McDougall, N, McQuillan, LM, Graham, UM, Lindsay, JR, Warnock, M, Campbell, B, Macauley, G, Hegarty, S, Spence, RAJ, Gordon, E, Boyd, K, Weir, CD, Wallace, IR, McEvoy, CT, Hunter, SJ, Hamill, LL, Ennis, CN, Woodside, JV, Bell, PM, Young, IS, McKinley, MC, Spence, A, Finnegan, S, Flannery, T, Harty, J, Haughey, N, Booth, K, Jeganathan, R, Leeper, AD, Dixon, JM, and Harrison, D
- Subjects
Abstracts ,respiratory system ,Article ,respiratory tract diseases - Abstract
Introduction Platelet activation has a role in the pathogenesis of acute lung injury (ALI). Observational data suggests aspirin treatment may prevent the development of ALI in critically ill patients. However, it is unknown if aspirin usage alters outcomes in patients with established ALI. Methods All patients with ALI were identified prospectively in a single large regional medical and surgical Intensive Care Unit (ICU) between December 2010 and July 2012. Demographic, clinical, and laboratory variables were recorded. Aspirin usage, both pre-hospital and during Intensive Care Unit (ICU) stay, was included. The primary outcome was ICU mortality. We used univariate and multivariate analyses to assess the impact of these variables on ICU mortality. Results Two hundred and two patients with ALI were included. 56 (28%) of these received aspirin either prehospital, in ICU, or both. Using multivariate logistic regression analysis, aspirin was found to be protective for ICU mortality. Conclusion Aspirin usage is associated with reduced mortality in patients with ALI. Whilst trials are ongoing to assess if aspirin can prevent ALI, these new data support the need for a clinical trial to investigate if aspirin improves outcomes in patients with established ALI., Aim To assess risk of major congenital malformations (MCMs) from exposure to anti-epileptic drugs (AEDs) during pregnancy. Methods Fifteen-year prospective observational study from 1996 until 2012. Outcomes are reported for valproate, carbamazepine, lamotrigine and levetiracetam monotherapy exposures. Main outcome measure is the MCM rate. Results Informative outcomes were available for 5510 cases. 1290 women were exposed to valproate monotherapy, 1718 to carbamazepine monotherapy, 2198 to lamotrigine monotherapy and 304 to levetiracetam monotherapy. The MCM risk with valproate monotherapy exposure in-utero is 6.7% (95% CI 5.5%-8.3%), compared to 2.6% with carbamazepine (95% CI 1.9%-3.5%), 2.3% with lamotrigine (95% CI 1.8%-3.1%) and 0.70% (95% CI 0.2%-2.5%) with levetiracetam. A significant dose effect is seen with valproate (p= 0.0006) and carbamazepine (p=0.03) exposed pregnancies, but not with exposure to lamotrigine (p=0.26) or levetiracetam (p=0.09). MCM rate for even the highest doses of lamotrigine (>400mg daily) were lower than the MCM rate observed in pregnancies exposed to less than 600mg daily of valproate (3.4% compared to 5.0%, p=0.35). Conclusions AED exposure during pregnancy increases the risk of MCM in the infants of women with epilepsy. In utero exposure to valproate carries a significantly higher MCM risk than lamotrigine (p=0.0001), levetiracetam (p=0.0001) or carbamazepine (p=0.0001) monotherapy. Our results are in contrast to previous suggestions that the MCM risk with exposure to low doses of valproate is preferable to that seen with exposure to high doses of lamotrigine. Together with recently published neurodevelopmental data, this data suggests that either lamotrigine or levetiracetam should be used as drugs of choice over valproate, even at low dose, in women of childbearing age with epilepsy., Background In recent years hypertonic saline has attracted increasing interest in the treatment of traumatic intracranial hypertension, and has a number of documented and theoretical advantages over other hyperosmolar agents. To date, no consensus has been achieved on the safest and most effective HTS concentration for administration. Aims The purpose of this paper was to evaluate the efficacy of intravenous bolus administration of highly concentrated (30%) hypertonic saline (HTS) in the treatment of refractory intracranial hypertension secondary to traumatic brain injury. Methods Patients were treated with an intravenous bolus of 10mls of 30% hypertonic saline. Multiple physiological parameters were measured throughout, including intracranial pressure, mean arterial pressure, cerebral perfusion pressure, pulse and inotrope/pressor requirements. Laboratory investigation pre and post HTS administration included: arterial pH, pCO2, HCO3, base excess; serum biochemistry measurements of sodium, potassium, chloride, urea and creatinine; and coagulation studies. Results TBI patients saw a rapid and significant reduction in ICP from a baseline value of 28 ± 5.31 mmHg to 18.44 ± 6.17 mmHg at 1-hour post HTS, a statistically significant reduction that was maintained for up to 7 hours. This response was maintained even with repeated HTS administration, which was also associated with an augmented cerebral perfusion pressure from a baseline of 58.0 ± 6.48 mmHg to 76.33 mmHg within 1 hour of HTS administration. Conclusions No associated harmful biochemical or haematological abnormalities were noted. In conclusion, highly concentrated 30% HTS appears to be both effective and safe in the management of refractory intracranial hypertension., Background Patients with rheumatoid Arthritis (RA) often report increasing joint pain and stiffness with colder, wet weather. Previous studies examining weather impact on pain severity have yielded contradictory results1-2. The relationship between disease activity in RA patients and weather variance has not been formally examined. Methods Patients attending Musgrave Park Hospital, Belfast; with a diagnosis of RA on anti-TNF were invited to participate. A longitudinal analysis of 133 patients was performed. Data collected at 5 time points included TJC, SJC, visual analogue score, ESR, CRP, and DAS-28. This was correlated with maximum/minimum temperature, hours of sunshine, rainfall, relative humidity, pressure and windspeed from a local weather station on day of attendance. A linear regression analysis was used to determine relationship between weather components, disease activity and pain. Results The weather-based components were extracted after a global factor analysis using data from all time-points revealed three components from the seven quantitative variables. Three components indicated by the factor analysis were as follows: temperature component, sunny/dry component, wet/windy component. All components were calculated from z-scores. A significant correlation was noted between low DAS-28 scores and sunny, dry conditions (p=0.001). Sunny and dry conditions ((hours of sunshine – relative humidity)/2) were associated with a DAS-28 reduction of 0.143 (95% CIs -0.230, -0.057) p=0.001. Higher temperatures (max temperature + min temperature/2) were associated with a DAS-28 reduction of 0.048 (95% CIs -0.129, 0.032), p=0.23. Wet and windy conditions (rainfall + wind-speed – pressure)/3 were associated with a higher DAS-28 (95% CIs -0.098, 0.123) p=0.82. Conclusions This study highlights statistically significant lower DAS-28 scores in sunny and dry conditions., Aim The Cardiac Computerised Tomography (CT) for the Assessment of Pain and Plaque (CAPP) study compared the economic and clinical outcomes of using cardiac CT compared to Exercise Stress Test (EST) in the patients with suspected stable chest pain. Method CAPP randomised 500 patients without known coronary artery disease to either EST or cardiac CT. All patients were followed up for clinical outcomes and for angina symptoms with the Seattle Angina Questionnaires (SAQ). Results Of the 500 patients 12 withdrew over the year, with 245 in the EST arm and 243 in CT arm receiving follow up. In the CT arm there were less chest pain Emergency Department attendances and unplanned admissions. Patients in the CT arm also had less secondary investigations and less time to diagnosis. The EST arm had 7 patients who underwent Coronary Artery Bypass Grafting (CABG) and 12 who had Percutaneous Coronary Intervention (PCI), compared to 8 CABG and 29 PCI in the CT arm. There was a significant improvement in domains of the SAQ scores at 1 year in the CT arm compared to EST (p =, Background There is currently a joint epilepsy and learning disability clinic for the South Eastern Health and Social Care Trust that began in October 2006. The clinic is for patients who would otherwise have to attend separate epilepsy and learning disability appointments. Aims Service evaluation and provide information for future comparison with similar services. Method There were forty-eight patients who attended the joint clinic during the period of October 2006, when the clinic first began and December 2011. Chart reviews for these patients were completed to evaluate the number of appointments attended and missed, reasons for referral, outcome from attendance at the clinic such as changes in seizure frequency and duration. Results The majority of patients attended one appointment (52 %) and missed no appointments (90%). The most common reason for referral was due to increase in seizure frequency (32%) and the most common intervention was change in medications (61%). The majority showed improvement in seizure frequency (68%) with a significant number having improvement in seizure duration (33%). Conclusion There was sixty-eight per cent that showed an improvement in seizure frequency. Thirty-three per cent showed an improvement in seizure duration while fourteen per cent had no further seizures. This would suggest that the clinic provides a useful tool to ensure good quality care to those people with learning disabilities and epilepsy., Random coagulation screening is a poor predictor of perioperative bleeding and has a poor yield in detecting haemostatic abnormalities. Current guidelines advocate selecting patients requiring coagulation screens using a structured bleeding history. Using a completed audit cycle as the vehicle for implementing change, ensuring guideline adherence, random ‘routine’ use of the £6.50 coagulation screen has decreased; avoiding patient anxiety, theatre delays, increased pressure on labs and a high cost to an already stretched NHS budget. One hundred surgical inpatients in the UHD were identified, and notes were reviewed to determine reasons for testing which were audited against current guidelines (NICE, GAIN-NI and BCSH) Initial audit found inappropriate testing was widespread; only 23% of samples were guideline adherent. Staff education sessions and poster distribution detailing the uses/limitations of coagulation screening, importance of bleeding history and current guidelines preceded the re-audit and closure of the loop which showed significant improvement; 61% of samples were now appropriate, a 265% increase in guideline compliance. It is clear that this completed audit-cycle has successfully implemented significant change in practice; improved cost efficiency, decreased theater delays, patient anxiety and unnecessary venepuncture; ultimately improving patient care., Objectives Bipolar I disorder (BPI) is known to have high rates of comorbid alcohol-use disorders (AUD) but the impact of this comorbidity on long-term outcomes such as episode recurrence and suicidal behaviour is unclear. Methods We compared lifetime demographic and clinical characteristics of illness for individuals with BPI and comorbid AUD (n= 436) to those with BPI without AUD (n=1020) using data from the Bipolar Disorder Research Network (BDRN). A logistic regression approach was used to test for associations. Results Comorbid BPI and AUD patients had a worse course of illness with significantly more suicidal ideation and a greater number of depressive and manic episodes compared to patients with BPI alone. Being male, unemployed, a current smoker, current cannabis use and the presence of rapid cycling were also significantly associated with comorbid BPI+AUD. Despite this, our data suggest that those with comorbid BPI+AUD were admitted less frequently to hospital than those with BPI alone. Conclusions Clinical services need to provide an integrated treatment approach for AUD which is comorbid with BPI. Stigma, interventional nihilism or self-medication may explain why patients with BPI+AUD appear to have been admitted less often to hospital. Early intervention and suicide prevention initiatives should be targeted at young men with BPI plus comorbid AUD., Current hip fractures guidelines recommend surgery within 36 hours of admission. The 2011 National Hip Fracture Database (NHFD) report shows our institute has the fewest patients meeting this target (9%). Northern Irelands’ exclusion from the “Best Practice Tariff” means no incentive-led treatment or prioritisation of hip fracture patients. We performed a systematic review of post-operative results to highlight deficiencies in delivery of patient care. We reviewed 702 patients admitted between September 2009 and April 2012. Patients were prospectively identified and added to our fracture outcome and research database (FORD). Results were compared to national average values from the NHFD. 16.7% of patients met the 36-hour target to theatre compared to the UK average of 66%. 81.7% underwent a pre-operative orthogeriatric review. The main reasons for surgical delay were inadequate theatre space (58%) and medically unfit patients (29%). After exclusion of medically unfit patients, medically fit patients were divided into delayed surgery and not delayed categories. Medically fit patients who had delayed surgery had inferior outcomes- longer hospital stay and higher mortality as an inpatient and at 30 days. Without a change in funding, Northern Ireland will struggle to compete with the UK mainland and decrease mortality in this patient group., Necrotising Fasciitis is a destructive infection of the skin and soft tissues, associated with significant mortality and morbidity. Survival from the condition necessitates patient referral to plastic surgery units for reconstructive procedures. We selected all cases referred to the regional plastic surgery service in Belfast over the last 6 years. We identified 46 referred patients (25 male: 21 female) and performed a retrospective case note review. The mean patient age was 59.4 years. Risk factors identified were diabetes, smoking, obesity, and immunocompromise. The most frequently affected anatomical site was the lower limb in 16 cases (35%). Infections contributed to 1555 hospital bed days with a median hospital stay per patient of 33.8 days. Necrotising fasciitis cases in Northern Ireland have been steadily increasing over the last 6 years reaching a peak in 2012. The majority are type 1 polymicrobial cases (50%). However, we observed a significant increase in type 2 Group A streptococcal infections over the timescale studied. The overall mortality rate was 28%. This is the first study from Northern Ireland, and one of the largest from the UK in the last 10 years, investigating the epidemiological features of necrotising fasciitis. It has identified a causative microbiology pool, along with changing bacterial trends that validate our current antibiotic policy. Mortality rates are consistent with those published from the rest of the UK., Background Preconceptual counselling (PC) to optimise seizure control and antiepileptic drug (AED) regimen is recommended as routine practice for women with epilepsy who are considering pregnancy. PC often takes place during routine outpatient clinic appointments, and previous studies have shown that information given in this context is often not retained. Methods Retrospective study of the outcome of PC in women attending our PC clinic over a ten-year period from 2003 to 2013. Comparison made to a cohort of pregnant women with epilepsy attending our Joint Epilepsy Obstetric Clinic from 2011-2012. Results A total of 122 women attended for preconceptual counselling. Overall, 74% of women attending for PC decided to continue to pregnancy without any change to their previous AED regimen. More women taking valproate, either in monotherapy or as part of a polytherapy regimen, made changes to their AED regimen following counselling than those on other drugs (42.8% compared to 4.9% for monotherapy exposures, p=0.0001 and 70% compared to 28.6% for polytherapy, p=0.03). Of those attempting to change from valproate regimens, women taking valproate as part of a polytherapy regimen were more likely achieve a sustained change than those on valproate monotherapy (85.7% compared to 50% on monotherapy). Pregnancy was subsequently recorded in 84 women. Rates of preconceptual folic acid consumption varied between the groups who had attended PC clinic and those who had not. More pregnant women who had attended PC clinic took high dose folic acid preconceptually (82.1%) compared to those attending neurology clinics (38.7%, p, Aim To assess the incidence and to circumstances associated with maternal mortality. Method Labour ward registration book was used to obtained details of patients who had died over the past 20 months. Medical records were then reviewed retrospectively. Results A total 48 patients were identified. Mean age was 25, and mean parity P1. 36% of patients self referred, 25% were referred from a health centre and 25% were referred from another hospital. Only 10% received antenatal care. The causes of death were severe eclampsia 32%; uterine rupture 28%; haemorrhage 24%; sepsis 10% and anaesthetic complications 6%. 75% of neonates were stillborn. 21% were comatose on arrival to hospital and died shortly afterwards. 11% died post operatively after surgery for ruptured uterus. On review only 14% of deaths may have been preventable with better inpatient management. Only 32% of patients had a discharge or death summary documented. Discussion The incidence of maternal mortality in Yirgalem was 1 in 67. This small study demonstrates that mothers in Ethiopia are still dying needlessly. There is an ongoing urgent effort required to reduce this unacceptably high incidence., Mobile phones have become increasingly integrated into the practice of doctors and allied medical professions. Recent studies suggest they represent reservoirs for pathogens with potential to cause nosocomial infections. We aimed to investigate the level of contamination on phones used on surgical wards and identify strategies for their safe use. The phones of 50 members of the surgical multidisciplinary team were swabbed using a standardized technique by two trained investigators. The samples streaked out using an automated specimen inoculator onto two types of culture media (Columbia blood agar and MacConkey agar). Colonies were identified and counted by a single trained investigator in a blinded fashion. Simultaneously a questionnaire investigating usage levels of phones was given to 150 healthcare workers. 60% of individuals sampled had some form of contaminant isolated from their phone. 31 (62%) of phones had only 3 colonies or less isolated on medium. No nosocomial bacterial contamination or drug resistant isolates were identified. Touch screen smart phones may be used safely in a clinical environment in the setting of effective adherence to hand hygiene policies., Background Lichen sclerosus (LS) is an autoimmune, inflammatory dermatosis with incidence quoted as 1:300-1:1000 and carrying a 2-4% lifetime risk of developing invasive vulval cancer. Appropriate management may reduce this risk. We audited the management of patients with biopsyconfirmed LS, against RCOG Green Top Guideline No 58. Methods A list of patients with biopsy-confirmed LS during 2012 was obtained from our Trust histopathology database. A proforma was devised and case notes reviewed. Results 23 dermatological and gynaecological patients were identified. In 3 cases, the notes were unobtainable. All were post-menopausal and aged 53-84 years. In over 60% of cases, there was no attempt to explore a wider relevant history including enquiry into incontinence or personal or family history of autoimmune or atopic conditions. Examination appeared limited and was poorly documented with only dermatologists achieving best practice through considering systemic examination. The decision to biopsy was usually taken at presentation (55%), the main indication being uncertain diagnosis (60%). Whilst recognised as safe and appropriate, only 35% had an outpatient biopsy. Following diagnosis, 10% were investigated for other autoimmune disorders and 25% were advised regarding general vulval skin care. Only 45% were prescribed ultra-potent steroids, 44% of whom were treated with the recommended regimen and appropriately instructed regarding use. In 25%, there was no communication of diagnosis, appropriate treatment or review to the patient or GP. Only 25% of patients were given an information leaflet and 20%, specifically informed regarding the risk of malignancy and the importance of selfsurveillance. Conclusion This audit highlights that the management of LS, a pre-malignant condition, is consistently falling below recommended practice. Continued education and the use of a proforma to guide management may significantly improve practice and potentially minimise disease progression., Background Transarterial chemoembolisation (TACE) is used to palliate patients with inoperable hepatocellular cancer (HCC) and as a holding procedure prior to transplantation. All TACE therapy in Northern Ireland is delivered by a single centre. Aims To determine outcomes for patients treated with TACE for HCC since 2006. Methods Patients with HCC diagnosed between 1 Jan 2006 and 31 Dec 2011 who underwent TACE therapy were identified. Relevant premorbid clinical information (UKELD, MELD, Childs-Pugh (CP) stage) was calculated. NI cancer registry database was used for mortality data. Results 75 patients (83% male, mean age 67yrs) with HCC had their first TACE during study period, rising from 5 in 2006 to 18 in 2011. Confirmed causes of cirrhosis included alcoholic liver disease, hepatitis B and C, haemochromatosis, primary biliary cirrhosis, and NASH. 49 patients were CP stage A, 24 were CP B and 1 CP C. Mean MELD score was 9.5 (range 6-20) and UKELD 48.5 (range 42-55). Mortality was 4% at 30 days, 39% at 1yr and 68.5% at 2yrs. Nine patients had TACE as a holding measure pretransplantation. Survival was influenced by age and gender. Conclusions The number of new patients receiving TACE for HCC in NI is rising. One year survival rate is 61%., A 58 year old non-diabetic caucasian man was admitted with a capillary glucose of 1.9mmol/l following an episode of confusion and disorientation. During his admission he had frequent episodes of nocturnal and early morning hypoglycaemia with capillary glucose 1000mU/l and C-peptide 19.6ug/l. Sulphonylurea screen was negative. Given the magnitude of serum insulin, insulin antibodies were measured and were positive. Serum insulin was corrected for the presence of antibodies using PEG precipitation yet remained elevated. CT imaging of pancreas was normal. Endoscopic ultrasound demonstrated a hyper-echoic abnormality in the tail of the pancreas measuring 13x11mm. He subsequently attended for calcium stimulated venous sampling which demonstrated high insulin production throughout the gland with no localisation. The patient started carbohydrate supplementation and 5mg daily prednisolone with resolution of hypoglycaemia over 8 weeks. Insulin autoimmune hypoglycaemia is a rare condition characterised by extremely high levels of insulin in the presence of anti-insulin antibodies. It is the third leading cause of hypoglycemia in Japan, but has rarely been described in the non-Asian population. Making the correct diagnosis is important to avoid an unnecessary pancreatic surgical procedure on a hypoglycemic patient., A previously well 27-year-old female presented with threemonth history of fatigue and weight loss. She did not report any other symptoms and there was no significant recent travel history. Clinically, there were no objective signs and basic investigations revealed a microcytic anaemia with raised inflammatory markers. HIV, hepatitis virology and liver specific antibodies were all negative. An OGD plus biopsies were normal. A CT abdomen revealed a 5cm soft tissue mass in the left side of the abdomen, separate from the pancreas and adjacent to the left kidney. At this point differential diagnoses included gastrointestinal stromal tumour, lymphoma, desmoid tumour and schwannoma. She proceeded to a laparotomy were a smooth walled lesion was resected from the proximal small bowel mesentery. Her postoperative recovery was unremarkable. The histology was returned as fitting a diagnosis of Castleman disease (CD). CD is a rare non-clonal lymphoproliferative disorder of unknown aetiology. There have been less than 2000 cases reported in the literature. Mesenteric CD is very rare event with only 43 cases reported in the English literature. Awareness of CD is important because the disease is potentially life threatening, is exceptionally rare and is incompletely understood., Aim Coagulation screens in surgical patients are routinely requested, often inappropriately. A coagulation screen costs £4.81, and often does not alter management. We performed four prospective audits (with audit cycle closed twice) of surgical inpatients in a district general hospital, comparing to Trust and NICE guidelines, to establish if coagulation screen requests were appropriate and identify cost implications. Methods All coagulation screen requests in surgical inpatients over two to five week periods were analysed and compared to Trust and NICE Guidelines. Medical notes and laboratory results were reviewed. This was repeated four times over a 3-year period (14 weeks in total). Results 313 coagulation screen requests were made over the four audit periods. Only 38% (119/313) requests were indicated as per guidelines. Inappropriate screens were typically requested for no apparent reason (29%), or unnecessary pre-operative, pre-procedure requests (28%), of the total 194 inappropriate requests. Only 3 unexpected coagulopathies were found. Over the four audit periods, total cost of inappropriate screens was £933.14 Conclusions Despite guidelines, there were a large number of unnecessary coagulation screens performed. Extrapolating our data over the 3-year period, £10,405.20 is spent on inappropriate screens., Whole diet observational studies suggest a beneficial effect on insulin resistance of diets rich in fruit and vegetables (FV). We examined the dose-response effect of FV consumption on insulin resistance in 105 overweight, non-diabetic individuals with no history of cardiovascular disease. After a 4 week wash-out diet of 1-2 portions FV per day, subjects were randomised to consume 1-2, 4 or 7 or more portions FV daily for 12 weeks. Insulin resistance was assessed pre and post intervention using a 2 step hyperinsulinemic euglycemic clamp. Between group comparisons of change were made with one-way ANOVA. Eighty-nine subjects completed the protocol; 28 (1-2FV), 29 (4FV) and 32 (7FV) attained a selfreported intake of 1.8, 3.8 and 7.0 portions per day (p, Observational studies suggest reduced vitamin D levels are associated with an increased incidence of type 2 diabetes mellitus (DM). We examined the relationship with insulin resistance (assessed using a two-step euglycaemic hyperinsulinaemic clamp) in 92 overweight, non-diabetic individuals with no history of cardiovascular disease - mean age 56 years (range 40 -77 years), 64% males, 36% females, body mass index 30.9 kg/m2 (range 26.4 – 36.9 kg/m2), fasting plasma glucose 5.8 mmol/L (range 4.9 – 7.0 mmol/L). Vitamin D was measured using an ultra performance liquid chromatography technique (UPLC) with tandem mass spectrometry. Statistical analysis was performed using Pearson's correlation coefficients and partial correlation. Mean total vitamin D concentration was 32.2 nmol/L. Pearson's correlation coefficients for vitamin D and GIR step 1 were -0.003 (p=0.98), GIR step 2 -0.036 (p=0.73) and HOMA-IR -0.163 (p=0.13). Partial correlation analysis did not elicit any significant correlations after correction for potential anthropometric, seasonal or gender confounders. We demonstrate no association between vitamin D and measures of insulin resistance in healthy overweight individuals at high risk of cardiovascular disease. We suggest that if vitamin D is associated with a reduced risk of DM, this may be due to effects on the beta-cell rather than on insulin resistance., Introduction Management of TBI in the DGH is based on national guidelines. There is little in the literature on the outcome of such patients. Methods Case notes, imaging and follow-up of 216 TBI patients admitted during one year were reviewed. Results The majority of patients admitted (median age: 50 years) were male (81%) and were assessed by trainee physicians; with 79% admitted between 5pm and 9am. 86 patients (41%) had evidence of alcohol consumption, 60 (29%) had decreased consciousness, 15 had dangerous mechanism of injury. 33 patients (22%) demonstrated an abnormality on initial CT brain including cerebral contusions (n=21), skull fractures (n=20), subdural (n=15), intraparenchymal (n=13), subarachnoid (n=6) and extradural haemorrhages (n=3). Four patients died shortly after initial presentation to the DGH due to a non-survivable TBI. Neurosurgical advice was sought on 19 patients - 13 were transferred of whom six required surgery; three eventually died. Glasgow Outcome Score (GOS) of the majority of available cases at last review was 5; a small number requiring minimal assistance (GOS=4, n=3); two patients had permanent disability (GOS=3, n=2). Conclusions Head injuries are common in a DGH and, while poor outcomes are rare, adherence to guidelines is essential to ensure optimal patient management., Introduction Locally, Cardiac Surgery consumes 2000 units of blood each year.1 Using Intraoperative cardiopulmonary bypass results in haemodilution and relative anaemia. Blood transfusion rate for the most commonly performed procedure, CABG is 59%. Resternotomy for bleeding occurs at a rate of 4.9% so we can assume that transfusion is occurring outside of post-operative blood loss. Red cell transfusion has adverse post-operative outcomes with a doubling of_5 year mortality (16% vs 7%).2 We established national trends in blood conservation and reviewed Retrograde Autologous Prime (RAP) of the bypass circuit as a method of blood conservation. Methodology An online survey was carried out across all UK and Ireland units. This was correlated with a local audit of patients receiving RAP versus no RAP. Forty-six patients undergoing cardiac surgery were prospectively studied. Results A response rate was seen of 88.6% to the questionnaire. The most common rate of blood transfusion reported was 25-50% with RAP used as a blood conservation method. In our cohort, the addition of RAP led to a 50% reduction in the blood transfusion rate (60.9% to 30.4%). Conclusions The method of RAP effectively reduces blood transfusion in this small study and we suggest it as part of patient blood management., Breast cancer is the most common cancer in the UK. Associated mortality is almost exclusively as a result of its ability to metastasise to and disrupt distant viscera. In order to improve survival rates in breast cancer, a better understanding of the mechanisms by which cancer disseminates is required. Here we describe a 3D assay which supports proliferation and invasion of primary breast cancer biopsies. Using real time video microscopy and histopathological techniques we identify a role for HER1 in the transformation of ER+ cancer cells into an ER- phenotype. Furthermore, activation of the HER1 receptor may result in epithelial cells developing mesenchymal characteristics along with increasingly invasive behaviour. Correlation with resected breast cancer specimens identified higher levels of HER1 expression alongside a reduction in ER expression over time in patients with recurrent breast cancer. Whilst further investigation is required in both the laboratory and clinical setting, these experiments indicate there may be a role for HER1 antagonists in the setting of ER+ breast cancer to reduce the rate of conversion to a more invasive basal phenotype and systemic dissemination.
- Published
- 2016
17. Frequency modulated hybrid photonic crystal laser by thermal tuning
- Author
-
Butler, S. M., primary, Bakoz, A. P., additional, Singaravelu, P. K. J., additional, Liles, A. A., additional, O’Shaughnessy, B., additional, Viktorov, E. A., additional, O’Faolain, L., additional, and Hegarty, S. P., additional
- Published
- 2019
- Full Text
- View/download PDF
18. Experimental electric field visualisation of multi-mode dynamics in a short cavity swept laser designed for OCT applications
- Author
-
Butler, T. P., primary, Goulding, D., additional, Slepneva, S., additional, O’Shaughnessy, B., additional, Hegarty, S. P., additional, Huyet, G., additional, and Kelleher, B., additional
- Published
- 2019
- Full Text
- View/download PDF
19. Thermally stable hybrid cavity laser based on silicon nitride gratings
- Author
-
Iadanza, S., primary, Bakoz, A. P., additional, Singaravelu, P. K. J., additional, Panettieri, D., additional, Schulz, S. A., additional, Devarapu, G. C. R., additional, Guerber, S., additional, Baudot, C., additional, Boeuf, F., additional, Hegarty, S., additional, and O’Faolain, L., additional
- Published
- 2018
- Full Text
- View/download PDF
20. Athermal Photonic Crystal Laser
- Author
-
O'Faolain, L., primary, Iadanza, S., additional, Bakoz, A. P., additional, Singaravelu, P., additional, Panettieri, D., additional, Schulz, S. A., additional, Devarapu, G.C.R., additional, Viktorov, Evgeny A., additional, and Hegarty, S., additional
- Published
- 2018
- Full Text
- View/download PDF
21. How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing?
- Author
-
Djatche, L., primary, Lee, S., additional, Singer, D., additional, Hegarty, S. E., additional, Lombardi, M., additional, and Maio, V., additional
- Published
- 2018
- Full Text
- View/download PDF
22. Sports Stars: Analyzing the Performance of Astronomers at Visualization-based Discovery
- Author
-
Fluke, C. J., primary, Parrington, L., additional, Hegarty, S., additional, MacMahon, C., additional, Morgan, S., additional, Hassan, A. H., additional, and Kilborn, V. A., additional
- Published
- 2017
- Full Text
- View/download PDF
23. Decision Support and Navigation to Increase Colorectal Cancer Screening among Hispanic Primary Care Patients
- Author
-
Myers, RE, primary, Stello, B, additional, Daskalakis, C, additional, Sifri, R, additional, DiCarlo, M, additional, Johnson, M, additional, Gonzalez, E, additional, Hegarty, S, additional, Rivera, A, additional, Gordis-Molina, L, additional, Shaak, K, additional, Quinn, A, additional, Careyva, B, additional, and Anderson-Ortiz, R, additional
- Published
- 2017
- Full Text
- View/download PDF
24. Mary, a Pipeline to Aid Discovery of Optical Transients
- Author
-
Andreoni, I., primary, Jacobs, C., additional, Hegarty, S., additional, Pritchard, T., additional, Cooke, J., additional, and Ryder, S., additional
- Published
- 2017
- Full Text
- View/download PDF
25. Classification of Variants of Reduced Penetrance in High Penetrance Cancer Susceptibility Genes: Framework for Genetics Clinicians and Clinical Scientists by CanVIG-UK (Cancer Variant Interpretation Group-UK)
- Author
-
Garrett, Alice, Allen, Sophie, Durkie, Miranda, Burghel, George J., Robinson, Rachel, Callaway, Alison, Field, Joanne, Frugtniet, Bethan, Palmer-Smith, Sheila, Grant, Jonathan, Pagan, Judith, McDevitt, Trudi, Rowlands, Charlie F., McVeigh, Terri, Hanson, Helen, Turnbull, Clare, Turnbull, C., Garrett, A., Loong, L., Choi, S., Torr, B., Allen, S., Durkie, M., Callaway, A., Drummond, J., Burghel, G.J., Robinson, R., Berry, I.R., Wallace, A.J., Eccles, D.M., Tischkowitz, M., Ellard, S., Hanson, H., Baple, E., Evans, D.G., Woodward, E., Lalloo, F., Samant, S., Lucassen, A., Znaczko, A., Shaw, A., Ansari, A., Kumar, A., Donaldson, A., Murray, A., Ross, A., Taylor-Beadling, A., Taylor, A., Innes, A., Brady, A., Kulkarni, A., Hogg, A.C., Bowden, A. Ramsay, Hadonou, A., Coad, B., McIldowie, B., Speight, B., DeSouza, B., Mullaney, B., McKenna, C., Brewer, C., Olimpio, C., Clabby, C., Crosby, C., Jenkins, C., Armstrong, C., Bowles, C., Brooks, C., Byrne, C., Maurer, C., Baralle, D., Chubb, D., Stobo, D., Moore, D., O'Sullivan, D., Donnelly, D., Randhawa, D., Halliday, D., Atkinson, E., Rauter, E., Johnston, E., Maher, E., Sofianopoulou, E., Petrides, E., McRonald, F., Pelz, F., Frayling, I., Corbett, G., Rea, G., Clouston, H., Powell, H., Williamson, H., Carley, H., Thomas, H.J.W., Tomlinson, I., Cook, J., Hoyle, J., Tellez, J., Whitworth, J., Williams, J., Murray, J., Campbell, J., Tolmie, J., Field, J., Mason, J., Burn, J., Bruty, J., Callaway, J., Grant, J., Del Rey Jimenez, J., Pagan, J., VanCampen, J., Barwell, J., Monahan, K., Tatton-Brown, K., Ong, K.R., Murphy, K., Andrews, K., Mokretar, K., Cadoo, K., Smith, K., Baker, K., Brown, K., Reay, K., McKay Bounford, K., Bradshaw, K., Russell, K., Stone, K., Snape, K., Crookes, L., Reed, L., Taggart, L., Yarram, L., Cobbold, L., Walker, L., Walker, L., Hawkes, L., Busby, L., Izatt, L., Kiely, L., Hughes, L., Side, L., Sarkies, L., Greenhalgh, K.-L., Shanmugasundaram, M., Duff, M., Bartlett, M., Watson, M., Owens, M., Bradford, M., Huxley, M., Slean, M., Ryten, M., Smith, M., Ahmed, M., Roberts, N., O'Brien, C., Middleton, O., Tarpey, P., Logan, P., Dean, P., May, P., Brace, P., Tredwell, R., Harrison, R., Hart, R., Kirk, R., Martin, R., Nyanhete, R., Wright, R., Martin, R., Davidson, R., Cleaver, R., Talukdar, S., Butler, S., Sampson, J., Ribeiro, S., Dell, S., Mackenzie, S., Hegarty, S., Albaba, S., McKee, S., Palmer-Smith, S., Heggarty, S., MacParland, S., Greville-Heygate, S., Daniels, S., Prapa, S., Abbs, S., Tennant, S., Hardy, S., MacMahon, S., McVeigh, T., Foo, T., Bedenham, T., Cranston, T., McDevitt, T., Clowes, V., Tripathi, V., McConnell, V., Woodwaer, N., Wallis, Y., Kemp, Z., Mullan, G., Pierson, L., Rainey, L., Joyce, C., Timbs, A., Reuther, A.-M., Frugtniet, B., DeSouza, B., Husher, C., Lawn, C., Corbett, C., Nocera-Jijon, D., Reay, D., Cross, E., Ryan, F., Lindsay, H., Oliver, J., Dring, J., Spiers, J., Harper, J., Ciucias, K., Connolly, L., Tsang, M., Brown, R., Shepherd, S., Begum, S., Daniels, S., Tadiso, T., Linton-Willoughby, T., Heppell, H., Sahan, K., Worrillow, L., Allen, Z., Watt, C., Hegarty, M., Mitchell, R., Coles, R., Nickless, G., Cojocaru, E., Doal, I., Sava, F., McCarthy, C., Jeeneea, R., Goudie, D., McConachie, M., Botosneanu, S., Kavanaugh, G., Russell, K., Sherlaw, C., Tsoulaki, O., Forde, C., Petley, E., Jones, A.-B., Oprych, K., Pryde, S., Hyder, Z., Elkhateeb, N., Braham, R., Hanington, L., Huntley, C., Irving, R., Sadan, A., Ramos, M., Elliot, C., Wren, D., Lobo, D., McLean, J., May, D., Kearney, L., Campbell, T., Asakura, K., Alwadi, L., O’Shea, R., Gabriel, J., Chiecchio, L., Bowman, P., Sutton, L.A., Walsh, C., Cloke, V., Ucanok, D., Davies, J., Pleasance, B., Maguire, E., Whaite, A., Best, S., Westbury, S., Logan, A., Navarajasegaran, D., Bench, A., Wightman, P., Cartwright, A., Higgs, E., J.Bott, Whitehouse, H., Stevens, J., Martin, D., Dunlop, J., Thomas, S., Sau, C., Farndon, S., Coleman, N., Angelini, P., Duff, M., Massey, H., Rowlands, C., Garcia-Petit, C., Gillespie, K., Alder, A., Middleton, E., Cassidy, C., Orfali, N., Webb, A., Luharia, A., Walker, N., Charlton, J., Andreou, A., Peddie, J., Khan, M., Wilkinson, L., Bezuidenhout, H., Edis, M., Callard, A., Ostrowski, P., Moverley, P., Bean, K., Dunne, A., Moleirinho, A., Waller, S., Cox, K., Greensmith, L., Brittle, A., Gossan, N., Freestone, L., Shak, C., Langford, T., Clinch, Y., Livesey, H., Borland, S., Joshi, A., Wall, K., Whitworth, A., Wilsdon, A., Edgerley, K., Pugh, S., Chrysochoidi, N., Mutch, S., McMullan, C., Johnston, Y., Muraru, M., May, A., Begum, R., Smith, C., Patel, R., Bhatnagar, I., Taylor, A., Brown, D., Willan, J., Taylor, S., Jones, K., Cox, K., Ramsden, C., Taiwo, O., Jaudzemaite, J., Sharmin, R., Young, L., C.O’Dubhshlaine, McSorley, L., Rodriguez, I. Abreu, Lillis, S., Alexopoulos, P., Mortensson, E., Kingham, L., Moore, R., Kosicka-Slawinska, M., Aslam, S., Wells, R., Carter, A., Warren, H., Rolf, E., Reed, H., Pearce, L., Lock, D., Ali, F., Kolozi, A., White, N., Wood, D., and Hayden, C.
- Abstract
Current practice is to report and manage likely pathogenic/pathogenic variants in a given cancer susceptibility gene (CSG) as though having equivalent penetrance, despite increasing evidence of inter-variant variability in risk associations. Using existing variant interpretation approaches, largely based on full-penetrance models, variants where reduced penetrance is suspected may be classified inconsistently and/or as variants of uncertain significance (VUS). We aimed to develop a national consensus approach for such variants within the Cancer Variant Interpretation Group UK (CanVIG-UK) multidisciplinary network.
- Published
- 2024
- Full Text
- View/download PDF
26. Injection-induced, tunable all-optical gating in a two-state quantum dot laser
- Author
-
Viktorov, E. A., primary, Dubinkin, I., additional, Fedorov, N., additional, Erneux, T., additional, Tykalewicz, B., additional, Hegarty, S. P., additional, Huyet, G., additional, Goulding, D., additional, and Kelleher, B., additional
- Published
- 2016
- Full Text
- View/download PDF
27. Photonic crystal reflector laser
- Author
-
Bakoz, A. P., primary, Liles, A. A., additional, Viktorov, E. A., additional, Faolain, L. O', additional, Huyet, G., additional, and Hegarty, S. P., additional
- Published
- 2016
- Full Text
- View/download PDF
28. Q-switch in injected quantum dot laser
- Author
-
Viktorov, E. A., primary, Erneux, T., additional, Tykalewicz, B., additional, Goulding, D., additional, Hegarty, S. P., additional, Huyet, G., additional, Dubinkin, I. N., additional, Fedorov, N. A., additional, and Kelleher, B., additional
- Published
- 2016
- Full Text
- View/download PDF
29. Lasing dynamics of photonic crystal reflector laser
- Author
-
Bakoz, Andrei P., additional, Liles, A. A., additional, Viktorov, E. A., additional, O'Faolain, L., additional, Habruseva, T., additional, Huyet, G., additional, and Hegarty, S. P., additional
- Published
- 2016
- Full Text
- View/download PDF
30. Dual state antiphase excitability in optically injected quantum dot lasers
- Author
-
Kelleher, B., additional, Goulding, D., additional, Tykalewicz, B., additional, Fedorov, N., additional, Dubinkin, I., additional, Hegarty, S. P., additional, Huyet, G., additional, Erneux, T., additional, and Viktorov, E. A., additional
- Published
- 2016
- Full Text
- View/download PDF
31. P.1.004 Novel neurotrophic strategy: interrogation of intracellular molecules regulating growth of midbrain dopaminergic neurons
- Author
-
Hegarty, S., primary, O'Leary, E., additional, Wyatt, S., additional, Sullivan, A., additional, and O'Keeffe, G., additional
- Published
- 2016
- Full Text
- View/download PDF
32. Optically induced hysteresis in a two-state quantum dot laser
- Author
-
Tykalewicz, B., primary, Goulding, D., additional, Hegarty, S. P., additional, Huyet, G., additional, Dubinkin, I., additional, Fedorov, N., additional, Erneux, T., additional, Viktorov, E. A., additional, and Kelleher, B., additional
- Published
- 2016
- Full Text
- View/download PDF
33. Emergence of resonant mode-locking via delayed feedback in quantum dot semiconductor lasers
- Author
-
Tykalewicz, B., primary, Goulding, D., additional, Hegarty, S. P., additional, Huyet, G., additional, Erneux, T., additional, Kelleher, B., additional, and Viktorov, E. A., additional
- Published
- 2016
- Full Text
- View/download PDF
34. Semiconductor mode-locked lasers with coherent dual-mode optical injection: simulations, analysis, and experiment
- Author
-
Arkhipov, R. M., primary, Habruseva, T., additional, Pimenov, A., additional, Radziunas, M., additional, Hegarty, S. P., additional, Huyet, G., additional, and Vladimirov, A. G., additional
- Published
- 2016
- Full Text
- View/download PDF
35. Optical ultrafast random number generation at 1 Tb/s using a turbulent semiconductor ring cavity laser
- Author
-
Butler, T., primary, Durkan, C., additional, Goulding, D., additional, Slepneva, S., additional, Kelleher, B., additional, Hegarty, S. P., additional, and Huyet, G., additional
- Published
- 2016
- Full Text
- View/download PDF
36. The Australian Square Kilometre Array Pathfinder: Performance of the Boolardy Engineering Test Array
- Author
-
McConnell, D., primary, Allison, J. R., additional, Bannister, K., additional, Bell, M. E., additional, Bignall, H. E., additional, Chippendale, A. P., additional, Edwards, P. G., additional, Harvey-Smith, L., additional, Hegarty, S., additional, Heywood, I., additional, Hotan, A. W., additional, Indermuehle, B. T., additional, Lenc, E., additional, Marvil, J., additional, Popping, A., additional, Raja, W., additional, Reynolds, J. E., additional, Sault, R. J., additional, Serra, P., additional, Voronkov, M. A., additional, Whiting, M., additional, Amy, S. W., additional, Axtens, P., additional, Ball, L., additional, Bateman, T. J., additional, Bock, D. C.-J., additional, Bolton, R., additional, Brodrick, D., additional, Brothers, M., additional, Brown, A. J., additional, Bunton, J. D., additional, Cheng, W., additional, Cornwell, T., additional, DeBoer, D., additional, Feain, I., additional, Gough, R., additional, Gupta, N., additional, Guzman, J. C., additional, Hampson, G. A., additional, Hay, S., additional, Hayman, D. B., additional, Hoyle, S., additional, Humphreys, B., additional, Jacka, C., additional, Jackson, C. A., additional, Jackson, S., additional, Jeganathan, K., additional, Joseph, J., additional, Koribalski, B. S., additional, Leach, M., additional, Lensson, E. S., additional, MacLeod, A., additional, Mackay, S., additional, Marquarding, M., additional, McClure-Griffiths, N. M., additional, Mirtschin, P., additional, Mitchell, D., additional, Neuhold, S., additional, Ng, A., additional, Norris, R., additional, Pearce, S., additional, Qiao, R. Y., additional, Schinckel, A. E. T., additional, Shields, M., additional, Shimwell, T. W., additional, Storey, M., additional, Troup, E., additional, Turner, B., additional, Tuthill, J., additional, Tzioumis, A., additional, Wark, R. M., additional, Westmeier, T., additional, Wilson, C., additional, and Wilson, T., additional
- Published
- 2016
- Full Text
- View/download PDF
37. FKBPL: A marker of good prognosis in breast cancer
- Author
-
Nelson, L, McKeen, HD, Marshall, A, Mulrane, L, Starczynski, J, Storr, SJ, Lanigan, F, Byrne, C, Arthur, K, Hegarty, S, Ali, AA, Furlong, F, McCarthy, HO, Ellis, IO, Green, AR, Rakha, E, Young, L, Kunkler, I, Thomas, J, Jack, W, Cameron, D, Jirström, K, Yakkundi, A, McClements, L, Martin, SG, Gallagher, WM, Dunn, J, Bartlett, J, O'Connor, D, Robson, T, Nelson, L, McKeen, HD, Marshall, A, Mulrane, L, Starczynski, J, Storr, SJ, Lanigan, F, Byrne, C, Arthur, K, Hegarty, S, Ali, AA, Furlong, F, McCarthy, HO, Ellis, IO, Green, AR, Rakha, E, Young, L, Kunkler, I, Thomas, J, Jack, W, Cameron, D, Jirström, K, Yakkundi, A, McClements, L, Martin, SG, Gallagher, WM, Dunn, J, Bartlett, J, O'Connor, D, and Robson, T
- Abstract
FK506-binding protein-like (FKBPL) has established roles as an anti-tumor protein, with a therapeutic peptide based on this protein, ALM201, shortly entering phase I/II clinical trials. Here, we evaluated FKBPL's prognostic ability in primary breast cancer tissue, represented on tissue microarrays (TMA) from 3277 women recruited into five independent retrospective studies, using immunohistochemistry (IHC). In a meta-analysis, FKBPL levels were a significant predictor of BCSS; low FKBPL levels indicated poorer breast cancer specific survival (BCSS) (hazard ratio (HR) = 1.30, 95% confidence interval (CI) 1.14-1.49, p < 0.001). The prognostic impact of FKBPL remained significant after adjusting for other known prognostic factors (HR = 1.25, 95% CI 1.07-1.45, p = 0.004). For the sub-groups of 2365 estrogen receptor (ER) positive patients and 1649 tamoxifen treated patients, FKBPL was significantly associated with BCSS (HR = 1.34, 95% CI 1.13-1.58, p < 0.001, and HR = 1.25, 95% CI 1.04-1.49, p = 0.02, respectively). A univariate analysis revealed that FKBPL was also a significant predictor of relapse free interval (RFI) within the ER positive patient group, but it was only borderline significant within the smaller tamoxifen treated patient group (HR = 1.32 95% CI 1.05-1.65, p = 0.02 and HR = 1.23 95% CI 0.99-1.54, p = 0.06, respectively). The data suggests a role for FKBPL as a prognostic factor for BCSS, with the potential to be routinely evaluated within the clinic.
- Published
- 2015
38. Realistic Imaging of Simulated Universes with the Theoretical Astrophysical Observatory.
- Author
-
Hegarty, S. E., Hassan, A. H., Croton, D. J., and Fluke, C. J.
- Published
- 2016
39. Resonant mode-locking via delayed feedback in quantum dot semiconductor lasers
- Author
-
Kelleher, B., primary, Goulding, D., additional, Tykalewicz, B., additional, Hegarty, S. P., additional, Huyet, G., additional, Erneux, T., additional, and Viktorov, E. A., additional
- Published
- 2015
- Full Text
- View/download PDF
40. Single shot, time-resolved measurement of the coherence properties of OCT swept source lasers
- Author
-
Butler, T., primary, Slepneva, S., additional, O’Shaughnessy, B., additional, Kelleher, B., additional, Goulding, D., additional, Hegarty, S. P., additional, Lyu, H.-C., additional, Karnowski, K., additional, Wojtkowski, M., additional, and Huyet, G., additional
- Published
- 2015
- Full Text
- View/download PDF
41. Phase and frequency dynamics of Fourier domain mode locked OCT lasers
- Author
-
Kelleher, B., additional, Goulding, D., additional, Slepneva, S., additional, O'Shaughnessy, B., additional, Butler, T., additional, Hegarty, S. P., additional, Vladimirov, A. G., additional, and Huyet, G., additional
- Published
- 2015
- Full Text
- View/download PDF
42. Phase evolution and instantaneous linewidth of a Fourier domain mode locked laser
- Author
-
Slepneva, S., additional, O'Shaughnessy, B., additional, Butler, T., additional, Kelleher, B., additional, Goulding, D., additional, Hegarty, S. P., additional, Vladimirov, A. G., additional, and Huyet, G., additional
- Published
- 2015
- Full Text
- View/download PDF
43. Phase and frequency dynamics of a short cavity swept-source OCT laser
- Author
-
Butler, T., additional, Goulding, D., additional, Slepneva, S., additional, O'Shaughnessy, B., additional, Kelleher, B., additional, Lyu, H-C., additional, Hegarty, S. P., additional, Vladimirov, A. G., additional, Karnowski, K., additional, Wojtkowski, M., additional, and Huyet, G., additional
- Published
- 2015
- Full Text
- View/download PDF
44. Effect of dynamical instability on timing jitter in passively mode-locked quantum-dot lasers
- Author
-
Pimenov, A., primary, Habruseva, T., additional, Rachinskii, D., additional, Hegarty, S. P., additional, Huyet, G., additional, and Vladimirov, A. G., additional
- Published
- 2014
- Full Text
- View/download PDF
45. Optical ultrafast random number generation at 1??Tb/s using a turbulent semiconductor ring cavity laser.
- Author
-
Butler, T., Durkan, C., Goulding, D., Slepneva, S., Kelleher, B., Hegarty, S. P., and Huyet, G.
- Published
- 2016
- Full Text
- View/download PDF
46. Dual state antiphase excitability in optically injected quantum dot lasers
- Author
-
Panajotov, Krassimir, Sciamanna, Marc, Valle, Angel, Michalzik, Rainer, Kelleher, B., Goulding, D., Tykalewicz, B., Fedorov, N., Dubinkin, I., Hegarty, S. P., Huyet, G., Erneux, T., and Viktorov, E. A.
- Published
- 2016
- Full Text
- View/download PDF
47. Phase and frequency dynamics of Fourier domain mode locked OCT lasers
- Author
-
Witzigmann, Bernd, Osiński, Marek, Henneberger, Fritz, Arakawa, Yasuhiko, Kelleher, B., Goulding, D., Slepneva, S., O'Shaughnessy, B., Butler, T., Hegarty, S. P., Vladimirov, A. G., and Huyet, G.
- Published
- 2015
- Full Text
- View/download PDF
48. Phase and frequency dynamics of a short cavity swept-source OCT laser
- Author
-
Fujimoto, James G., Izatt, Joseph A., Tuchin, Valery V., Butler, T., Goulding, D., Slepneva, S., O'Shaughnessy, B., Kelleher, B., Lyu, H-C., Hegarty, S. P., Vladimirov, A. G., Karnowski, K., Wojtkowski, M., and Huyet, G.
- Published
- 2015
- Full Text
- View/download PDF
49. Phase evolution and instantaneous linewidth of a Fourier domain mode locked laser
- Author
-
Fujimoto, James G., Izatt, Joseph A., Tuchin, Valery V., Slepneva, S., O'Shaughnessy, B., Butler, T., Kelleher, B., Goulding, D., Hegarty, S. P., Vladimirov, A. G., and Huyet, G.
- Published
- 2015
- Full Text
- View/download PDF
50. Lasing dynamics of photonic crystal reflector laser
- Author
-
Panajotov, Krassimir, Sciamanna, Marc, Valle, Angel, Michalzik, Rainer, Bakoz, Andrei P., Liles, A. A., Viktorov, E. A., O'Faolain, L., Habruseva, T., Huyet, G., and Hegarty, S. P.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.